ArticleEClinicalMedicine2026

Weight loss and blood pressure lowering with GLP-1 receptor agonists and multi-hormone receptor modulators in overweight and obesity: a systematic review and meta-regression of phase 3 clinical trials.

Massimo Nardone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.